Recent advances in MR spectroscopy expand its applications in neurologic disease.
MRS extends the diagnostic power of MRI by displaying the biochemical composition of a selected tissue or region. When MR imaging shows a lesion, the evaluation of the chemical composition by MRS can help determine whether biopsy, observation or medical treatment is indicated. It can save some patients from biopsy prior to radiation or chemotherapy. In the future, both the image information and the spatial distribution of chemical constituents throughout the brain will be displayed with techniques such as chemical shift imaging (CSI). MRS improves the accuracy of MRI diagnosis and prognosis. MRS is performed at many sites in the country and is reimbursed by many insurers. MRS has been approved by the AMA for a CPT-4 code for reimbursement.
Prost
R W
RW
Department of Radiology, Medical College of Wisconsin, Milwaukee 53226, USA.
Mark
L P
LP
Rand
S D
SD
Kim
T A
TA
Haughton
V M
VM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001927:Brain Diseases / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D014922:Wisconsin